A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies

Reproductive Biology and Endocrinology

Volumn 3, Issue , 2005, Pages

  Banerjee, Subhasis ^a   Smallwood, Alan ^a   Chambers, Anne E ^a   Papageorghiou, Aris ^b   Loosfelt, Hugues ^b   Spencer, Kevin ^c   Campbell, Stuart ^a   Nicolaides, Kypros ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BICÊTRE HOSPITAL   (France)

^c HAROLD WOOD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CHORIONIC GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; PROGESTERONE; ISOPROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; CHORION VILLUS SAMPLING; CONTROLLED STUDY; CORPUS LUTEUM; CORRELATION ANALYSIS; DOWN SYNDROME; EXON; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GESTATION PERIOD; GLYCOSYLATION; GONADOTROPIN BLOOD LEVEL; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PLACENTA; PREGNANCY; PROGESTERONE RELEASE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RNA SYNTHESIS; STEADY STATE; TRANSCRIPTION INITIATION; TROPHOBLAST; ALPHA CHAIN; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; CHEMISTRY; CHORION VILLUS; GENETICS; METABOLISM; MOUSE; PRENATAL DEVELOPMENT; TRISOMY; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHORIONIC VILLI; DOWN SYNDROME; FEMALE; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; HUMANS; MICE; PREGNANCY; PROTEIN ISOFORMS; RECEPTORS, LH; RNA, MESSENGER; TRISOMY;

EID: 24344466017     PISSN: 14777827     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-3-25     Document Type: Article

References (65)

1. Hassold TJ, Jacobs PA: Trisomy in man. Ann Rev Genet 1983, 18:69-97.
2. Warburton D, Fraser FC: Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 1964, 16:1-25.
3. Hassold T, Chen N, Funkhouser J, Jooss T, Manuel B, Matsuura J, Matsuyama A, Wilson C, Yamane JA, Jacobs PA: A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet 1980, 44:151-178.
4. Gras L, McBain J, Trounson A, Kola I: The incidence of chromosomal aneuploidy in stimulated and unstimulated (natural) uninseminated human oocytes. Hum Reprod 1992, 7:1396-1401.
5. Hook EB, Cross PK, Schreinemachers DM: Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983, 249:2034-2038.
6. Goldstein H, Nielsen KG: Rates and survival of individuals with trisomy 13 and 18. Data from a 10-year period in Denmark. Clin Genet 1988, 34:366-372.
7. Baty BJ, Blackburn BL, Carey JC: Natural history of trisomy 18 and trisomy 13: 1. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 1994, 49:175-188.
8. Nicolaidis P, Petersen MB: Origin and mechanisms of non-disjunction in human autosomal trisomies. Hum Reprod 1998, 13:313-319.
9. Wisniewski KE, Wisniewski HM, Wen GY: Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985, 17:278-282.
10. Hitzler JK, Zipursky A: Origins of leukaemia in children with Down syndrome. Nat Rev Cancer 2005, 5:11-20.
11. Menendez M: Down syndrome, Alzheimer's disease and seizures. Brain Dev 2005, 27:246-252.
12. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH: A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999, 13:231-237.
13. Hoshina M, Boothby M, Boime I: Cytological localization of chorionic gonadotropin alpha and placental lactogen mRNAs during development of the human placenta. J Cell Biol 1982, 93:190-198.
14. Licht P, Russu V, Wildt L: On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Semin Reprod Med 2001, 19:37-47.
15. Bahado-Singh RO, Oz AU, Kingston JM, Shahabi S, Hsu CD, Cole L: The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenat Diagn 2002, 22:478-481.
16. Muller F, Savey L, Le Fiblec B, Bussieres L, Ndayizamba G, Colau JC, Giraudet P: Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol 1996, 175:37-40.
17. Spencer K: Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome. Clin Chem 1991, 37:809-814.
18. Spencer K, Macri JN, Aitken DA, Connor JM: Free beta-hCG as first-trimester marker for fetal trisomy. Lancet 1992, 339:1480.
19. Rousseau-Merck MF, Misrahi M, Atger M, Loosfelt H, Milgrom E, Berger R: Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21. Cytogenet Cell Genet 1990, 54:77-79.
20. Atger M, Misrahi M, Sar S, Le FL, Dessen P, Milgrom E: Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5′ non-coding regions. Mol Cell Endocrinol 1995, 111:113-123.
21. Loosfelt H, Misrahi M, Atger M, Salesse R, Vu Hai-Luu Thi MT, Jolivet A, Guiochon-Mantel A, Sar S, Jailal B, Garnier J: Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain. Science 1989, 245:525-528.
22. McFarland KC, Sprengel R, Phillips HS, Kohler M, Rosemblit N, Nikolics K, Segaloff DL, Seeburg PH: Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 1989, 245:494-499.
23. Clouser CL, Menon KM: N-linked glycosylation facilitates processing and cell surface expression of rat luteinizing hormone receptor. Mol Cell Endocrinol 2005, 235:11-19.
24. Ascoli M, Fanelli F, Segaloff DL: The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 2002, 23:141-174.
25. Hipkin RW, Sanchez-Yague J, Ascoli M: Identification and characterization of a luteinizing hormone/chorionic gonadotropin (LH/CG) receptor precursor in a human kidney cell line stably transfected with the rat luteal LH/CG receptor complementary DNA. Mol Endocrinol 1992, 6:2210-2218.
26. Min L, Ascoli M: Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor. Mol Endocrinol 2000, 14:1797-1810.
27. VuHai-LuuThi MT, Misrahi M, Houllier A, Jolivet A, Milgrom E: Variant forms of the pig lutropin/choriogonadotropin receptor. Biochemistry 1992, 31:8377-8383.
28. Bukovsky A, Indrapichate K, Fujiwara H, Cekanova M, Ayala ME, Dominguez R, Caudle MR, Wimalsena J, Elder RF, Copas P, Foster JS, Fernando RI, Henley DC, Upadhyaya NB: Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease. Reprod Biol Endocrinol 2003, 1:46.
29. Tsai-Morris CH, Buczko E, Wang W, Dufau ML: Intronic nature of the rat luteinizing hormone receptor gene defines a soluble receptor subspecies with hormone binding activity. J Biol Chem 1990, 265:19385-19388.
30. Kremer H, Kraaij R, Toledo SPA, Post M, Fridman JB, Hayashida CY, van Reen M, Milgrom E, Ropers HH, Mariman E, Themmen APN, Brunner HG: Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nature Genet 1995, 9:160-164.
31. Gromoll J, Eiholzer U, Nieschlag E, Simoni M: Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 2000, 85:2281-2286.
32. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I: Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 2001, 15:172-183.
33. Rao CV, Lei ZM: Consequences of targeted inactivation of LH receptors. Mol Cell Endocrinol 2002, 187:57-67.
34. Dorman SE, Holland SM: Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998, 101:2364-2369.
35. Fieschi C, Dupuis S, Picard C, Smith CI, Holland SM, Casanova JL: High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics 2001, 107:E48.
36. Banerjee S, Smallwood A, Chambers AE, Nicolaides K: Quantitative recovery of immunoreactive proteins from clinical samples following RNA and DNA isolation. Biotechniques 2003, 35:450-2, 454, 456.
37. Smallwood A, Papageorghiou A, Nicolaides K, Alley MK, Jim A, Nargund G, Ojha K, Campbell S, Banerjee S: Temporal regulation of the expression of syncytin (HERV-W), maternally imprinted PEG10, and SGCE in human placenta. Biol Reprod 2003, 69:286-293.
38. Banerjee S, Smallwood A, Moorhead J, Chambers AE, Papageorghiou A, Campbell S, Nicolaides K: Placental expression of interferon-gamma (IFN-gamma) and its receptor IFN-gamma R2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J Clin Endocrinol Metab 2005, 90:944-952.
39. Spencer K, Berry E, Crossley JA, Aitken DA, Nicolaides KH: Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy? Prenat Diagn 2000, 20:311-317.
40. Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K: Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem 2002, 39:567-576.
41. Minegishi T, Tano M, Abe Y, Nakamura K, Ibuki Y, Miyamoto K: Expression of luteinizing hormone/human chorionic gonadotrophin (LH/HCG) receptor mRNA in the human ovary. Mol Hum Reprod 1997, 3:101-107.
42. Reinholz MM, Zschunke MA, Roche PC: Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary. Gynecol Oncol 2000, 79:264-271.
43. Madhra M, Gay E, Fraser HM, Duncan WC: Alternative splicing of the human luteal LH receptor during luteolysis and maternal recognition of pregnancy. Mol Hum Reprod 2004, 10:599-603.
44. Xie YB, Wang H, Segaloff DL: Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. J Biol Chem 1990, 265:21411-21414.
45. Bacich DJ, Rohan RM, Norman RJ, Rodgers RJ: Characterization and relative abundance of alternatively spliced luteinizing hormone receptor messenger ribonucleic acid in the ovine ovary. Endocrinology 1994, 135:735-744.
46. Koo YB, Ji I, Ji TH: Characterization of different sizes of rat luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acids. Endocrinology 1994, 134:19-26.
47. Meduri G, Charnaux N, Loosfelt H, Jolivet A, Spyratos F, Brailly S, Milgrom E: Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 1997, 57:857-864.
48. Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS: Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem 2004, 279:20539-20545.
49. de RN, Milgrom E: Inherited disorders of GnRH and gonadotropin receptors. Mol Cell Endocrinol 2001, 179:83-87.
50. Wu SM, Leschek EW, Rennert OM, Chan WY: Luteinizing hormone receptor mutations in disorders of sexual development and cancer. Front Biosci 2000, 5:D343-D352.
51. Brizot ML, Jauniaux E, Mckie AT, Farzaneh F, Nicolaides KH: Placental expression of alpha and beta subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome. Hum Reprod 1995, 10:2506-2509.
52. Eldar-Geva T, Hochberg A, deGroot N, Weinstein D: High maternal serum chorionic gonadotropin level in Downs' syndrome pregnancies is caused by elevation of both subunits messenger ribonucleic acid level in trophoblasts. J Clin Endocrinol Metab 1995, 80:3528-3531.
53. Goshen R, Gonik B, Ariel I, Weiss Y, de-Groot N, Hochberg A: High levels of maternal serum human chorionic gonadotropin in Down syndrome pregnancies: the possible role of a transcription factor on chromosome 21. Fetal Diagn Ther 1999, 14:106-111.
54. Frendo JL, Vidaud M, Guibourdenche J, Luton D, Muller F, Bellet D, Giovagrandi Y, Tarrade A, Porquet D, Blot P, Evain-Brion D: Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J Clin Endocrinol Metab 2000, 85:3700-3707.
55. Goshen R: What factors regulate HCG production in Down's syndrome pregnancies?. Screening for Down's syndrome using HCG concentrations - a common practice but still an enigma. Mol Hum Reprod 1999, 5:893-895.
56. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ: Regulation of human placental development by oxygen tension. Science 1997, 277:1669-1672.
57. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ: Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001, 40:4077-4086.
58. Kliman HJ, Feinberg RF: Human trophoblast-extracellular matrix (ECM) interactions in vitro: ECM thickness modulates morphology and proteolytic activity. Proc Natl Acad Sci U S A 1990, 87:3057-3061.
59. Damsky CH, Fisher SJ: Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. Curr Opin Cell Biol 1998, 10:660-666.
60. Jauniaux E, Bao S, Eblen A, Li X, Lei ZM, Meuris S, Rao CV: HCG concentration and receptor gene expression in placental tissue from trisomy 18 and 21. Mol Hum Reprod 2000, 6:5-10.
61. Hamalainen T, Kero J, Poutanen M, Huhtaniemi I: Transgenic mice harboring murine luteinizing hormone receptor promoter/beta-galactosidase fusion genes: different structural and hormonal requirements of expression in the testis, ovary, and adrenal gland. Endocrinology 2002, 143:4096-4103.
62. Nakamura K, Yamashita S, Omori Y, Minegishi T: A splice variant of the human luteinizing hormone (LH) receptor modulates the expression of wild-type human LH receptor. Mol Endocrinol 2004, 18:1461-1470.
63. Hershkovitz R, Erez O, Sheiner E, Landau D, Mankuta D, Mazor M: Elevated maternal mid-trimester chorionic gonadotropin > or = 4 MoM is associated with fetal cerebral blood flow redistribution. Acta Obstet Gynecol Scand 2003, 82:22-27.
64. Apaja PM, Harju KT, Aatsinki JT, Petaja-Repo UE, Rajaniemi HJ: Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. J Biol Chem 2004, 279:1899-1906.
65. Liu B, Hong JS: Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003, 304:1-7.